Oppenheimer Remains Bullish on Geron Corp (GERN) Following Two Articles in NEJM

Pre-Open Stock Movers 08/03: (PSEM) (MM) (GERN) (LCI) Higher; (FIVE) (KERX) (JOY) Lower (more...)

Pericom Semiconductor (NASDAQ: PSEM) 39% HIGHER; Diodes (NASDAQ: DIOD) and Pericom Semiconductor Corporation (NASDAQ: PSEM) announced that Diodes Incorporated and Pericom have entered into an Agreement and Plan of Merger that provides for the acquisition of Pericom by Diodes. At the effective date of the merger, each share of Pericom will be converted into the right to receive $17.00 in cash, without interest.

Millennial Media, Inc. (NYSE: MM) 30.5% HIGHER; AOL... More

After-Hours Stock Movers 09/02: (GERN) (LCI) (SEAC) Higher; (FIVE) (PLNT) (VRNT) Lower (more...)

Geron Corp (NASDAQ: GERN) 18.7% HIGHER; announced the publication of two papers in The New England Journal of Medicine (NEJM) in which the companys telomerase inhibitor, imetelstat, was shown to have disease-modifying activity thought to be associated with selective inhibition of the malignant progenitor cell clones responsible for the underlying disease in two hematologic myeloid... More

Geron Corp (GERN) Announces Publication of Two Papers in NEJM Highlighting Imetelstat

Geron Corp (Nasdaq: GERN) announced the publication of two papers in The New England Journal of Medicine (NEJM) in which the companys telomerase inhibitor, imetelstat, was shown to have disease-modifying activity thought to be associated with selective inhibition of the malignant progenitor cell clones responsible for the underlying disease in two hematologic myeloid malignancies, essential thrombocythemia (ET) and myelofibrosis (MF). The papers are available online in the September 3rd issue at www.NEJM.org.

The data in the ET and MF study publications in The New England Journal of Medicine provide compelling... More